| Issue Date | Title | Author(s) |
| 18-Dec-2023 | Amidst an amygdala renaissance in Alzheimer’s disease | Stouffer, KM; Grande, X; Duezel, E; Johansson, M; Creese, B; Witter, MP; Miller, MI; Wisse, LEM; Berron, D |
| 12-Aug-2023 | Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment | Arenare, G; Manca, R; Caffarra, P; Venneri, A |
| 22-Feb-2021 | A Comparison of Neurocognitive Decline in Older Adults in Same-Sex and Opposite-Sex Relationships | Manca, R; Venneri, A |
| 23-Mar-2024 | Compassionate mind training for people with Parkinson's disease: A pilot study and predictors of response | Della Morte, S; Berti, E; Lalli, C; Modugno, N; Morgante, F; Schrag, A; Makovac, E; Ricciardi, L |
| 26-Jan-2021 | Genetic risk for alzheimer’s disease, cognition, and mild behavioral impairment in healthy older adults | Creese, B; Arathimos, R; Brooker, H; Aarsland, D; Corbett, A; Lewis, C; Ballard, C; Ismail, Z |
| 5-Jan-2022 | Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease | Creese, B; Ismail, Z |
| 29-Jul-2023 | Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO | Ismail, Z; Leon, R; Creese, B; Ballard, C; Robert, P; Smith, EE |
| 6-Jun-2025 | Sativex (nabiximols) for the treatment of Agitation & Aggression in Alzheimer’s dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial | Albertyn, CP; Guu, T-W; Chu, P; Creese, B; Young, A; Velayudhan, L; Bhattacharyya, S; Jafari, H; Kaur, S; Kandangwa, P; Carter, B; Aarsland, D |
